Gilead Sciences has been looking for a win for Trodelvy after two surprise trial failures earlier this year. But it looks ...
When AstraZeneca’s Alexion picked up rare disease specialist Syntimmune in 2018 for $ | A Delaware judge agreed that ...
With the expiration of a contract to produce antibiotic medicines for Sandoz, GSK will shutter a 75-year-old manufacturing ...
BMS ran its first C2C4C event in 2014, when an employee worked with colleagues to put together a team of 53 oncology staffers ...
Three months on, Eli Lilly has closed the books on its search for a new chief financial officer. And as with its previous CFO ...
After opting out of Teva’s $4.25 billion national opioid settlement last year, the city of Baltimore has secured its own payout through a settlement deal worth $80 million. | The city scored its own ...
Why is PDA’s Universe of Pre-Filled Syringes and Injection Devices Conference the must-attend event of the year? Get an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback